Sign in: Staff/Students
Professor Sir Munir Pirmohamed
This year’s European Laboratory Research and Innovation Group (ELRIG) Drug Discovery conference is being hosted in Liverpool, and will feature a number of leading researchers in the area of drug development, including Professor Sir Munir Pirmohamed.
The flagship Drug Discovery event, 13-14 October 2016 at the Arena & Convention Centre Liverpool, is the UK’s largest free to attend event of its kind. It will bring together industry leaders from across the pharma, biotech, academia and vendor communities to discuss future opportunities for novel therapeutic discovery.
Leading clinical experts
Professor Sir Munir Pirmohamed, one of the country’s leading clinical experts, based at University of Liverpool’s Institute of Translational Medicine, will be Plenary Speaker at this event.
Professor Pirmohamed will speak on Drug Safety in Drug Development.
The six main sessions will cover: Innovations in Chemistry; Oncology & Immunology; Innovations in Predictive & Translational Models; Assay Development, Screening & Emerging Technologies; Coming Closer to the Patient – Cells and Genes in Therapy and Diagnostics; and Target Identification & Validation.
Disrupting previous thinking
The conference will also explore innovative technologies and approaches that can be used to overcome drug development challenges.
Another addition to the conference this year is a series of Core Technologies Workshops & Vendor Tutorials. These will provide a more informal, interactive environment for attendees to discuss key issues and future directions in workshops coordinated by leaders in the fields.
Dr Peter Simpson, director of N8 Research Partnership, which is partnering with ELRIG, and who co-chaired last year’s Drug Discovery conference, said: “This event will be a superb opportunity to hear about high quality science, from leading thinkers and innovators as they challenge and disrupt previous thinking.
“As Director of N8, I’m absolutely convinced that bringing the whole community of academia, SMEs and major companies together truly fosters innovation and collaboration. It is great that this event is returning to the North, a region where Health Innovation is highlighted as a major economic capability. Great advancement will come from quality research insights, informal discussions, and networking, to the benefit the drug discovery and life science communities.”
For more information about the event please visit: http://elrig.org/drug-discovery-2016-registration/
You must be logged in to post a comment.
All recent news
Staff and students invited to Government pilot event: Change Business for Good
Stephen Lawrence Day 2021
New research to explore experiences of walking and creativity during COVID-19
Unpreneur: A free enterprise and start-up bootcamp for students
Explore hidden world of microbes in new comic book
Our paper on immune responses to COVID vaccine (mostly Pfizer) in 237 healthcare workers, 124 #SARSCoV2 naïve and 113 previously infected, from the PITCH consortium @pitchstudy is out as a pre-print today.
See if you can spot us in the new @NetflixUK series, The Irregulars! 📽️
Our @VictoriaGallery appears in it, as well as other locations across the city including St George’s Plateau, the Palm House in Sefton Park and Falkner Street in the Georgian Quarter.
Professor Michael Parkinson CBE, author of 1985's Liverpool on the Brink, and Liverpool Beyond the Brink in 2019, analyses the Caller Report, the Gov's Best Value inspection into Liverpool City Council